| Identification | Back Directory | [Name]
Imidazo[2,1-b]thiazole, 6-[4-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butoxy]phenyl]- | [CAS]
207277-37-0 | [Synonyms]
RGH 1756
RGH-1756
Imidazo[2,1-b]thiazole, 6-[4-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butoxy]phenyl]- | [Molecular Formula]
C26H30N4O2S | [MDL Number]
MFCD27976879 | [MOL File]
207277-37-0.mol | [Molecular Weight]
462.61 |
| Hazard Information | Back Directory | [Description]
RGH 1756 is an atypical antipsychotic with high affinity to dopamine D(3) receptors that results in a unique pattern of c-Fos induction. | [Uses]
RGH-1756 is an atypical antipsychotic that has a strong and selective antagonist activity on human D3 and less pronounced activity on human D2L and 5HT1A receptors[1]. | [References]
[1] Terjéki E, Kapás M. An HPLC/UV method for the determination of RGH-1756 in dog and rat plasma. J Pharm Biomed Anal. 2001 Mar;24(5-6):913-20. DOI:10.1016/s0731-7085(00)00559-8 |
|
|